Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,879 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy.
Yoshimura A, Yamamoto Y, Nishikawa T, Fujita M, Inoue T, Kondo F, Hayashi T, Kawamura N, Nagahara A, Nakai Y, Nakayama M, Nishimura K. Yoshimura A, et al. Among authors: inoue t. Int Cancer Conf J. 2023 Sep 7;13(1):26-32. doi: 10.1007/s13691-023-00630-w. eCollection 2024 Jan. Int Cancer Conf J. 2023. PMID: 38187183 Free PMC article.
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction.
Kunimasa K, Oka T, Hara S, Yamada N, Oizumi S, Miyashita Y, Kamada R, Funamoto T, Kawachi H, Kawamura T, Inoue T, Kuhara H, Tamiya M, Nishino K, Matsunaga T, Imamura F, Fujita M, Kumagai T. Kunimasa K, et al. Among authors: inoue t. Lung Cancer. 2021 Mar;153:186-192. doi: 10.1016/j.lungcan.2020.10.021. Epub 2020 Nov 16. Lung Cancer. 2021. PMID: 33277055
Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib.
Kunimasa K, Kamada R, Oka T, Oboshi M, Kimura M, Inoue T, Tamiya M, Nishikawa T, Yasui T, Shioyama W, Nishino K, Imamura F, Kumagai T, Fujita M. Kunimasa K, et al. Among authors: inoue t. JACC CardioOncol. 2020 Mar 17;2(1):1-10. doi: 10.1016/j.jaccao.2020.02.003. eCollection 2020 Mar. JACC CardioOncol. 2020. PMID: 34396203 Free PMC article.
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study.
Kunimasa K, Sugimoto N, Kawamura T, Yamasaki T, Honma K, Nagata S, Kukita Y, Fujisawa F, Inoue T, Yamaguchi Y, Kitasaka M, Wakamatsu T, Yamai T, Yamamoto S, Hayashi T, Inoue T, Tamiya M, Imamura F, Nishimura K, Nishino K. Kunimasa K, et al. Among authors: inoue t. Thorac Cancer. 2022 Nov;13(21):2970-2977. doi: 10.1111/1759-7714.14643. Epub 2022 Sep 13. Thorac Cancer. 2022. PMID: 36100256 Free PMC article.
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.
Nishikawa T, Inoue T, Otsuka T, Kuno I, Kukita Y, Nakamura H, Ikeda Y, Yasui T, Shioyama W, Oka T, Honma K, Hatakeyama K, Miyata H, Isei T, Ishihara R, Kumagai T, Nishimura K, Fujita M. Nishikawa T, et al. Among authors: inoue t. PLoS One. 2022 Nov 15;17(11):e0275865. doi: 10.1371/journal.pone.0275865. eCollection 2022. PLoS One. 2022. PMID: 36378654 Free PMC article.
Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study.
Kadokawa Y, Inoue S, Tatsumi A, Uchida M, Fujita K, Takagi M, Inoue T, Ohe S, Nakai Y, Otsuka T, Abe Y, Nakabori T, Isei T, Kumagai T, Nishimura K, Ohkawa K. Kadokawa Y, et al. Among authors: inoue t, inoue s. JGH Open. 2023 Feb 13;7(2):87-97. doi: 10.1002/jgh3.12868. eCollection 2023 Feb. JGH Open. 2023. PMID: 36852148 Free PMC article.
11,879 results
You have reached the last available page of results. Please see the User Guide for more information.